About Index Trending news
Lists
Pricing
Kineta, Inc

Kineta, Inc

Kineta, Inc

Kineta is a nationally-recognized biotechnology company developing novel autoimmune, antiviral and chronic pain therapeutics

Elsewhere

Alexa global traffic share

Twitter followers

21 Jul 2016
$1,500,000
Grant
The Wellcome Trust

Kineta Secures NIAID Funding to Expand Testing of Immune Modulators

yahoo
+2
25 May 2016
$760,780
Venture capital

SEC FORM D/A

sec